Composition
Levepsy Tablets:
Each scored film coated tablet contains:
Levetiracetam ……..........…….. 500 mg
Levepsy Oral Solution:
Each 1 ml contains:
Levetiracetam ……........……….. 100 mg
Inactive ingredients:
Levepsy Tablets:
Microcrystalline cellulose PH 101, povidone K 30, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, hydoxypropyl methylcellulose 2910, polyethylene glycol 4000, titanium dioxide, quinoline yellow lake.
Levepsy Oral Solution:
Sodium cyclamate, methylparaben sodium, propylparaben sodium, citric acid anhydrous, sodium citrate, sorbitol 70%, cherry menthol flavour, carmosine red 85%, purified water.

Therapeutic Indications
Levepsy is indicated as Monotherapy:
In the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Levepsy is indicated as Adjunctive therapy:
In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 1 month of age with epilepsy.
In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.